Cargando…
Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury
Autores principales: | De Franceschi, Lucia, Costa, Enrico, Dima, Francesco, Morandi, Matteo, Olivieri, Oliviero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167571/ https://www.ncbi.nlm.nih.gov/pubmed/32381323 http://dx.doi.org/10.1016/j.ejim.2020.04.020 |
Ejemplares similares
-
Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out
por: De Franceschi, Lucia, et al.
Publicado: (2020) -
Chloroquine/hydroxycloroquine and COVID-19: need to know more about
por: Cassone, Antonio, et al.
Publicado: (2020) -
Interesting case of G6PD deficiency anemia with severe hemolysis
por: Chhabra, Anupam, et al.
Publicado: (2013) -
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency()
por: Schilling, William H.K., et al.
Publicado: (2020) -
“Hemolysis, or not Hemolysis, that is the Question”. Use of Hydroxychloroquine in a Patient with COVID-19 Infection and G6PD Deficiency
por: Sgherza, Nicola, et al.
Publicado: (2020)